Relationship between premature ejaculation and genetic polymorphisms of the dopamine transporter gene (SLC6A3)

BJU International

Volumn 108, Issue 2, 2011, Pages 292-296

  Safarinejad, Mohammad Reza ^a,b  

^a Private Practice of Urology and Andrology   (Iran)

^b NONE   (Iran)

Author keywords

dopamine transporter; gene expression; genetics; polymorphism; premature ejaculation

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BASE PAIRING; CONTROLLED STUDY; DAT1 GENE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PREMATURE EJACULATION; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EJACULATION; EPIDEMIOLOGIC METHODS; GENE FREQUENCY; GENOTYPE; HUMANS; IRAN; MALE; POLYMORPHISM, GENETIC; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; YOUNG ADULT;

EID: 79960030564     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09809.x     Document Type: Article

References (36)

1. Read S, King M, Watson J,. Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner. J Public Health Med 1997; 19: 387-91 (Pubitemid 28031265)
2. Waldinger MD,. The neurobiological approach to premature ejaculation. J Urol 2002; 168: 2359-67 (Pubitemid 35402615)
3. Waldinger MD, Berendsen HHG, Blok BFM, et al,. Premature ejaculation and SSRI-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res 1998; 92: 111-8 (Pubitemid 28223582)
4. Schapiro B,. Premature ejaculation, a review of 1,130 cases. J Urol 1943; 50: 374-9
5. Waldinger MD, Rietschel M, Nothen MM, et al,. Familial occurrence of primary premature ejaculation. Psychiatr Genet 1998; 8: 37-40 (Pubitemid 28181559)
6. Safarinejad MR,. Polymorphisms of the serotonin transporter gene and their relation to premature ejaculation in individuals from Iran. J Urol 2009; 181: 2656-61
7. Ozbek E, Tasci AI, Tugcu V, et al,. Possible association of the 5-HTTLPR serotonin transporter promoter gene polymorphism with premature ejaculation in a Turkish population. Asian J Androl 2009; 11: 351-5
8. Safarinejad MR,. Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. J Clin Psychopharmacol 2007; 27: 444-50 (Pubitemid 47430572)
9. Waldinger MD, Hengeveld MW, Zwinderman AH, et al,. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo controlled study with fluoxetine, fluvoxamine, paroxetine and sertraline. J Clin Psychopharmacol 1998; 18: 274-81
10. Safarinejad MR,. Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a doubleblind, placebo-controlled, fixed-dose, randomized study. Clin Neuropharmacol 2006; 29: 243-52 (Pubitemid 44439996)
11. Safarinejad MR, Hosseini SY,. Safety and efficacy of citalopram in the treatment of premature ejaculation: a double blind placebo-controlled, fixed dose, randomized study. Int J Impot Res 2006; 18: 164-9 (Pubitemid 43336482)
12. Safarinejad MR,. Analysis of association between the 5-HTTLPR and STin2 polymorphisms in the serotonin-transporter gene and clinical response to a selective serotonin reuptake inhibitor (sertraline) in patients with premature ejaculation. BJU Int 2009; Jun 22. [Epub ahead of print]
13. McMahon CG, Abdo C, Incrocci L, et al,. Disorders of orgasm and ejaculation in men. J Sex Med 2004; 1: 58-65 (Pubitemid 40424667)
14. Waldinger MD, Dave DH, Olivier B,. On-demand SSRI treatment of premature ejaculation: pharmacodynamic limitations for relevant ejaculation delay and consequent solutions. J Sex Med 2005; 2: 121-31 (Pubitemid 40468200)
15. Hsieh JT, Chang HC, Law HS, et al,. In vivo evaluation of serotoninergic agents and α-adrenergic blockers on premature ejaculation by inhibiting the seminal vesicle pressure response to electrical nerve stimulation. Br J Urol 1998; 82: 237-40
16. McIntosh TK, Barfield RJ,. Brain monoaminergic control of male reproductive behavior. II. Dopamine and the post-ejaculatory refractory period. Behav Brain Res 1984; 12: 267-73 (Pubitemid 14094267)
17. Bártová D, Bouchal M,. Thioridazine treatment of ejaculatio praecox. Act Nerv Super (Praha) 1965; 7: 244-5
18. Ditman KS,. Inhibition of ejaculation by chlorprothixene. Am J Psychiatry 1964; 120: 1004-5
19. Bannon MJ,. The dopamine transporter: role in neurotoxicity and human disease. Toxicol Appl Pharmacol 2005; 204: 355-60 (Pubitemid 40545237)
20. Gainetdinov RR, Jones SR, Caron MG,. Functional hyperdopaminergia in dopamine transporter knock-out mice. Biol Psychiatry 1999; 46: 303-11 (Pubitemid 29335911)
21. Vandenbergh DJ, Persico AM, Hawkins AL, et al,. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992; 14: 1104-6 (Pubitemid 23053054)
22. Fuke S, Suo S, Takahashi N, et al,. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 2001; 1: 152-6 (Pubitemid 33757602)
23. Mill J, Asherson P, Browes C, et al,. Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 2002; 114: 975-9 (Pubitemid 35379243)
24. Simsek M, Al-Sharbati M, Al-Adawi S, et al,. Association of the risk allele of dopamine transporter gene (DAT1*10) in Omani male children with attention-deficit hyperactivity disorder. Clin Biochem 2005; 38: 739-42 (Pubitemid 41019574)
25. Inoue-Murayama M, Adachi S, Mishima N, et al,. Variation of variable number of tandem repeat sequences in the 3′-untranslated region of primate dopamine transporter genes that affects reporter gene expression. Neurosci Lett 2002; 334: 206-10 (Pubitemid 35350858)
26. First MB, Spitzer RL, Gibbon M, et al,. Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV). Washington, DC: American Psychatric Press, 1997
27. Miller SA, Dykes DD, Polesky HF,. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215-8
28. Sullivan PF, Fifield WJ, Kennedy MA, et al,. Novelty seeking and a dopamine transporter gene polymorphism (DAT1). Biol Psychiatry 1997; 42: 1070-2 (Pubitemid 27496438)
29. Carrasco X, Rothhammer P, Moraga M, et al,. Genotypic interaction between DRD4 and DAT1 loci is a high risk factor for attention-deficit/hyperactivity disorder in Chilean families. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 51-4 (Pubitemid 43062542)
30. Hsieh JT, Liu SP, Hsieh CH, et al,. An in vivo evaluation of the therapeutic potential of sympatholytic agents on premature ejaculation. BJU Int 1999; 84: 503-6 (Pubitemid 29419423)
31. Bannon MJ, Michelhaugh SK, Wang J, et al,. The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders. Eur Neuropsychopharmacol 2001; 11: 449-55 (Pubitemid 33026519)
32. Mitchell RJ, Howlett S, Earl L, et al,. Distribution of the 3′ VNTR polymorphism in the human dopamine transporter gene in world populations. Hum Biol 2000; 72: 295-304 (Pubitemid 30231295)
33. Nakatome M, Honda K, Islam MN, et al,. Amplification of DAT1 (human dopamine transporter gene) 3′ variable region in the Japanese population. Hum Hered 1995; 45: 262-5
34. Nakatome M, Honda K, Tun Z, Kato Y, et al,. Genetic polymorphism of the 3′ VNTR region of the human dopaminergic function gene DAT1 (human dopamine transporter gene) in the Mongolian population. Hum Biol 1998; 68: 509-15 (Pubitemid 126447491)
35. Kim JW, Kim BN, Cho SC,. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case-control association study in a Korean sample. J Psychiatr Res 2006; 40: 730-7
36. Waldinger MD,. Lifelong premature ejaculation: from authority-based to evidence-based medicine. BJU Int 2004; 93: 201-7